Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong
· Delayed Price · Currency is HKD 1.400
+0.060 (4.48%)
At close: Mar 10, 2026
HKG:0950 Revenue
Lee's Pharmaceutical Holdings had revenue of 694.82M HKD in the half year ending June 30, 2025, with 35.63% growth. This brings the company's revenue in the last twelve months to 1.44B, up 19.80% year-over-year. In the year 2024, Lee's Pharmaceutical Holdings had annual revenue of 1.40B with 32.95% growth.
Revenue (ttm)
1.44B
Revenue Growth
+19.80%
P/S Ratio
0.57
Revenue / Employee
1.39M
Employees
1,036
Market Cap
824.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.40B | 346.94M | 32.95% |
| Dec 31, 2023 | 1.05B | -180.11M | -14.61% |
| Dec 31, 2022 | 1.23B | -33.01M | -2.61% |
| Dec 31, 2021 | 1.27B | 49.44M | 4.06% |
| Dec 31, 2020 | 1.22B | -2.20M | -0.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fusen Pharmaceutical Company | 264.08M |
| Pak Fah Yeow International | 199.55M |
| Zhongzhi Pharmaceutical Holdings | 2.20B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| China NT Pharma Group Company | 20.45M |
| Chia Tai Enterprises International | 4.17B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| Wai Yuen Tong Medicine Holdings | 721.27M |